Atlantic Private Wealth
VKTX icon

Atlantic Private Wealth’s Viking Therapeutics VKTX Stock Holding History

Atlantic Private Wealth’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.3K Hold
500
– – 0.01% 178
2026
Q2 		$19.5K Hold
500
– – 0.01% 170
2026
Q1 		$16.3K Hold
500
– – 0.01% 183
2025
Q4 		$17.6K Hold
500
– – 0.01% 176
2025
Q3 		$13.1K Hold
500
– – 0.01% 173
2025
Q2 		$13.2K Hold
500
– – 0.01% 172
2025
Q1 		$12.1K Buy
500
+50
+11% +$1.58K 0.01% 172
2024
Q4 		$18.1K Buy
+450
New +$25.7K 0.01% 147

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Atlantic Private Wealth's VKTX Position: Q3 2026 in Review

Atlantic Private Wealth held its Viking Therapeutics (VKTX) position steady in Q3 2026 at 500 shares worth $16.3K. The position accounts for 0.01% of the portfolio, ranked #178.

Atlantic Private Wealth first reported a position in VKTX in Q4 2024 and has held it in 8 quarters since. The position peaked at $19.5K in Q2 2026. 267 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • Atlantic Private Wealth held 500 shares of Viking Therapeutics worth $16.3K as of Q3 2026.
  • Atlantic Private Wealth left its Viking Therapeutics share count unchanged in Q3 2026.
  • Viking Therapeutics made up 0.01% of Atlantic Private Wealth's portfolio in Q3 2026, its #178 holding.
  • Atlantic Private Wealth first reported a position in Viking Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • Atlantic Private Wealth's Viking Therapeutics position peaked at $19.5K in Q2 2026.
  • 267 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Atlantic Private Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.